 |
||||||||||||
|
Event Listings
Across 3 content-packed days, the field’s thought leaders from AstraZeneca, Tesaro, Artios, Metabomed, Sierra Oncology and many more will be sharing their insight and lessons learned, collectively enabling the community to: - Achieve Efficacy across Contexts: Define the key steps required to identify and therapeutically exploit robust synthetic lethal interactions that are conserved across a variety of defined contexts - Optimize Patient Stratification: Streamline clinical trials by improving the recruitment and stratification of patients, increasing efficiency - Apply Lessons Learned from PARP Inhibitors: Analyze key aspects of the development of PARP inhibitors through case studies, and determine how we can use these insights to advance R&D of new synthetic lethal drugs - Exploit Key Targets of Mechanisms of Resistance: Assess the most effective methods for identifying and utilizing mechanisms of resistance to optimize cancer treatment - Harness Bioinformatics and Computational Approaches: Exploring the latest advances in identifying clinically relevant synthetic lethal interactions from genome widescreens Join your peers in Boston to gain unique and novel insights into methods for accelerating your synthetic lethal drug development. Brochure: https://go.evvnt.com/160417-1 Booking: https://go.evvnt.com/160417-2 Prices: Conference + 2 Workshops (Industry): USD 4097 Conference + 1 Workshop (Industry): USD 3398 Conference Only (Industry): USD 2799 Workshop Only (Industry): USD 699 Conference + 2 Workshops (Academic): USD 2868 Conference + 1 Workshop (Academic): USD 2379 Conference Only (Academic): USD 1959 Workshop Only (Academic): USD 699 Speakers: Graeme Smith - Chief Scientific Officer - Artios Pharma Ltd., J. Carl Barrett - Vice President of Translational science in Oncology - AstraZeneca, Aviad Tsherniak - Associate Director of Cancer Data Science - Broad Institute of MIT and Harvard, Alexandra Grassian - Senior Scientist - Epizyme, Cyril Benes - Director for the Center for Molecular Therapeutics - Mass General Center for Cancer Research, Simone Botti - CEO - Metabomed Ltd., René Bernards - Professor of molecular carcinogenesis - Netherlands Cancer Institute, Bill Forrester - Principal Investigator - Novartis, Dr. Mark Kowalski - Chief Medical Officer - Sierra Oncology, Jeffrey H. Hanke - Executive Vice President of Research & Development and Chief Scientific Officer - TESARO, Kevin Coleman - Executive Director Translational Research & Development Experimental Biology -, TESARO, Angelique Whitehurst - Associate Professor - UT Southwestern Medical Center, Lars Zender - Professor and Chairman of the Department of Internal Medicine VIII and Scientific Director of the Comprehensive Cancer Center - Tübingen-Stuttgart, Eytan Ruppin - Professor of Computer Science & Director of the Center of Bioinformatics and, Computational Biology (CBCB) - University of Maryland, Stephane Angers - Professor for the Faculty of Pharmacy & Dept of Biochemistry - University of Toronto, Daniel Durocher - Senior Investigator -Lunenfeld-Tanenbaum Research Institute Mount Sinai Hospital
Registration Website: https://go.evvnt.com/160417-0 Submitted by Love Evvnt, Evvnt on Wednesday, 31 January 2018 at 9:00 AM Category: Business |
||||||||||||
|
|
||||||||||||
 |
||||||||||||
|
Scoopasia v1.0b. Copyright © 2019
Today is Wednesday, 20 February 2019 |
||||||||||||
Want to get your press releases, event listings, and job ads on Scoopasia? 
| Journalist's Toolbox |  |
|
Hello journalist, welcome to Scoopasia--a powerful online resource for media information in Asia. Scoopasia has press releases and media events for every beat and industry. All content on Scoopasia is 100% FREE. You don't even need to login!
(Instant Information Request) The easiest way to ask questions and request information from the PR community. Drill down, dig deep, for media information the way you want it. Resources and tools you can't do without. | |
| PR Tools |
|
Scoopasia Blog Search
Search the largest handpicked collection of Asia's most prominent and influential blogs. |
| Resources |
|
More Coming Soon... |
| Latest Jobs |
| Sorry, there are currently no entries posted here. |
